Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Veterinary Defibrillators Market Size & Share 2026-2035
Report ID: GMI14192
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Veterinary Defibrillators Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Veterinary Defibrillators Market Size
The veterinary defibrillators market was valued at USD 74.6 million in 2025, is projected to reach USD 78.9 million in 2026, and is expected to expand at a 5.8% CAGR (2026–2035) to USD 131.1 million by 2035.
Veterinary Defibrillators Market Key Takeaways
Market Leader: Mindray Medical International Limited led with over 15% market share in 2025.
Leading Players: Top 5 players in this market include Shenzhen Comen Medical Instruments, Digicare Biomedical, Avante Animal Health, Meditech Equipment, Mindray Medical International Limited, which collectively held a market share of 26% in 2025.
The market is evolving from a narrowly specialized emergency-care category into a broader critical-care equipment purchase. Demand is increasingly shaped by companion-animal medicine, the upgrading of emergency departments, and procurement preference for devices that combine defibrillation with monitoring and pacing functions.
GMI Analyst View
Based on our proprietary market modeling and discussions with industry stakeholders, we expect the global market to reach USD 98.9 million in 2030. We view this midpoint as evidence that adoption is moving beyond a limited base of referral centers as more veterinary facilities build formal emergency-response capability into their capital-equipment planning.
Veterinary Defibrillators Market Trends, Growth Drivers & GMI Forecast Outlook
Growth rests on a practical shift in veterinary capital allocation: emergency readiness, anesthesia monitoring, and cardiac-response capability are increasingly evaluated together. Demand strengthens where pet populations, practice investment, and clinical training advance in parallel, while pricing and regulatory friction remain material constraints on broader adoption.
Key Drivers
*Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.*
Companion-animal ownership supports equipment demand indirectly but persistently. A larger installed population of pets expands the caseload flowing through primary care, referral networks, anesthesia suites, and emergency facilities. Cardiac disease remains a clinically significant concern in dogs and cats, reinforcing the need for hospitals to maintain a credible response pathway for acute cardiac events [3]Purina Institute. “Cardiac Conditions.” purinainstitute.com.
Infrastructure investment converts this clinical need into procurement. New practices, facility expansions, and corporate-network standardization each create points at which emergency-care equipment is specified, rather than purchased opportunistically. Replacement demand is also becoming more consequential as established hospitals move away from stand-alone rescue devices toward integrated platforms that can support use across emergency and perioperative settings.
Technology is widening the commercial role of the defibrillator. Biphasic delivery, automated guidance, and integrated patient monitoring reduce the operational separation between resuscitation equipment and routine critical-care tools. This expands the value proposition for facilities that need to justify capital expenditure against utilization across several clinical workflows.
Key Restraints
*Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.*
Resuscitation outcomes and equipment adoption are closely linked to clinical readiness. Where teams lack structured protocols, rehearsal, and post-event review, a defibrillator can be perceived as an underused capital asset rather than a component of a coordinated emergency-care system. Training organizations have elevated awareness of evidence-based veterinary CPR, but the quality and availability of implementation remain uneven across facility types [4]RECOVER Initiative. “2024 CPR Guidelines.” recoverinitiative.org.
Cost creates a different barrier. Independent practices may recognize the clinical case for dedicated equipment while deferring purchase because utilization is episodic and budgets must also accommodate imaging, anesthesia, laboratory, and surgical investments. Suppliers that can offer credible mid-tier configurations, service support, and flexible channel models are better positioned to convert this latent demand.
Regulatory fragmentation compounds the commercial challenge outside established markets. Approval requirements, import processes, and local service arrangements can delay product availability even where clinical demand is developing. This makes regulatory planning and distributor capability important determinants of whether emerging-market opportunity becomes addressable revenue.
GMI Analyst View
We believe the market's central execution issue is not the existence of clinical need, but whether practices can pair equipment investment with training, maintenance, and reliable clinical protocols. Suppliers that reduce this implementation burden should have a stronger route into general-practice settings than those competing solely on device specifications.
Veterinary Defibrillators Market Segment Analysis
By Product Type
The veterinary defibrillators market generated USD 46.3 million from automated external defibrillators in 2025, while this segment is projected to expand at a 6.1% CAGR (2026–2035). AEDs address a broad operating environment because guided rhythm analysis can support teams with varying levels of resuscitation experience. Dual-mode configurations are particularly relevant as hospitals seek devices that accommodate both standardized emergency workflows and clinician-directed intervention.
Manual defibrillators are projected to reach USD 47.2 million by 2035 and accounted for 38% of the market in 2025. Demand for manual platforms remains concentrated in specialist hospitals, teaching facilities, and advanced emergency departments. These settings value direct control over shock delivery and integration with more complex clinical decision-making, particularly across varied animal sizes and presentations.
By Modality
External defibrillators generated USD 53.7 million in 2025 and are projected to record a 5.9% CAGR (2026–2035). External devices remain the practical foundation of veterinary defibrillation because they can be deployed across the widest range of animal-care environments. Their role is reinforced by workflow familiarity, portability, and compatibility with the needs of both emergency treatment and perioperative preparedness.
Internal defibrillators are projected to reach USD 35.4 million by 2035 and represented 28% of market revenue in 2025. Internal applications are more specialized, serving surgical, academic, and research environments where direct cardiac access is clinically appropriate. Adoption therefore depends less on broad practice expansion than on the development of advanced referral and procedural capability.
By Technology
Biphasic defibrillators are projected to reach USD 104.9 million by 2035 and are expected to grow at a 6.9% CAGR (2026–2035). Biphasic technology is increasingly embedded in purchasing criteria because it aligns clinical-performance expectations with the operational requirements of modern veterinary emergency care. Its installed-base expansion also supports demand for devices designed around integrated monitoring, pacing, and more versatile user interfaces.
Monophasic defibrillators generated USD 20.9 million in 2025 and are projected to expand at a 2.3% CAGR (2026–2035). Monophasic systems retain a role in cost-sensitive and legacy-equipment settings, but their commercial position is primarily shaped by replacement rather than new clinical preference. The slower trajectory reflects a market moving toward platforms that deliver greater functionality per purchase.
By Animal Type
Dogs generated USD 41.0 million in 2025 and are forecast to advance at a 5.6% CAGR (2026–2035). Canine care is the principal demand base for veterinary defibrillation because dogs represent a large share of companion-animal emergency and cardiology caseloads. Referral pathways, breed-specific cardiac risk, and owner willingness to pursue advanced treatment all support equipment demand in facilities serving canine patients.
Cats are projected to contribute USD 51.1 million by 2035 and represented 39% of the market in 2025. Feline emergency care presents a different clinical pattern, with the need for rapid assessment and stabilization often elevating the value of equipment that combines monitoring and resuscitation capabilities. Facilities with strong feline caseloads are therefore increasingly evaluating integrated platforms rather than emergency-only devices.
Horses generated USD 3.0 million in 2025 and are projected to account for 4% of market revenue in 2035. Equine demand remains specialized and is tied to surgical centers, referral hospitals, and facilities capable of managing the practical requirements of large-animal critical care. Equipment design, clinical protocols, and service support must be adapted to this distinct care setting.
Other animal types are projected to reach USD 3.9 million by 2035 and are expected to grow at a 10.0% CAGR (2026–2035). This category is supported by rising care standards in zoological medicine, wildlife rehabilitation, and exotic-animal practice. Although demand remains comparatively niche, it offers suppliers a differentiated route to growth where species-specific equipment design and clinical support are valued.
By Functionality
Standard defibrillators generated USD 48.5 million in 2025 and are projected to account for 58% of market revenue in 2035. Standard devices remain important where practices prioritize a focused emergency-care purchase and need a familiar operating model. Their continued relevance is strongest in facilities where monitoring equipment is already installed separately or where capital budgets are tightly segmented.
Multiparameter-capability platforms are projected to reach USD 55.1 million by 2035 and are expected to grow at a 7.8% CAGR (2026–2035). Integrated functionality changes the investment case by allowing one platform to support defibrillation, monitoring, anesthesia oversight, and acute-care workflows. This broad utilization profile can make higher-specification systems more attractive to referral hospitals and corporate groups seeking to standardize equipment across sites.
By End Use
Veterinary hospitals and clinics generated USD 58.2 million in 2025 and are forecast to expand at a 5.7% CAGR (2026–2035). Hospitals and clinics form the market's core purchasing base because they manage the largest share of acute presentations and perioperative procedures. Corporate networks and urban referral facilities are especially influential because their procurement processes can formalize defibrillation capability across multiple locations.
Veterinary research institutes are projected to reach USD 17.0 million by 2035 and represented 12% of market revenue in 2025. Research institutions require precision, repeatability, and documentation capability for cardiac physiology, anesthesia, and resuscitation work. Their purchasing decisions are therefore often influenced by technical performance and compatibility with controlled research protocols.
Other end-use settings generated USD 7.5 million in 2025 and are projected to account for 10% of market revenue in 2035. This category includes deployment environments where mobility, portability, and specialized service arrangements can matter as much as conventional hospital infrastructure. Suppliers addressing these settings must balance equipment robustness with an accessible ownership model.
GMI Analyst View
We see product convergence as the defining segment-level shift. The strongest commercial proposition is increasingly an integrated critical-care platform rather than a single-purpose emergency device, which raises the importance of software, monitoring capability, clinical workflow design, and after-sales support in supplier differentiation.
Veterinary Defibrillators Market Regional Analysis
North America Veterinary Defibrillators Market Analysis
The veterinary defibrillators market in North America represented 42% of global revenue in 2025 and is projected to reach USD 52.4 million by 2035. North America benefits from a developed companion-animal care system, active specialty referral networks, and a sizable corporate-practice presence. Demand is increasingly driven by replacement cycles and upgrades toward multiparameter-capable equipment rather than basic market formation.
U.S.
The U.S. market generated USD 28.2 million in 2025 and is projected to reach USD 47.2 million by 2035. Capital investment by corporate veterinary groups, emergency hospitals, and specialist practices supports a deep equipment market. Standardization of emergency protocols and service expectations makes the U.S. a critical arena for suppliers able to provide clinical training and dependable lifecycle support.
Canada
Canada generated USD 3.1 million in 2025 and represented 10% of North American revenue in 2025. The market is supported by established urban companion-animal care networks and growing specialization in major metropolitan areas. Demand is more concentrated than in the U.S., making distributor coverage and relationships with referral facilities particularly important.
Europe Veterinary Defibrillators Market Analysis
Europe generated USD 20.9 million in 2025 and is expected to grow at a 5.0% CAGR (2026–2035). European demand reflects varied national practice structures but a shared trend toward more formal emergency-care capability. University hospitals, referral centers, and corporate practice groups are key purchasers, while country-specific capital budgets and regulatory processes continue to shape adoption timing.
Germany
Germany generated USD 4.2 million in 2025 and accounted for 20% of European revenue in 2025. Germany's market is underpinned by well-capitalized practices, teaching hospitals, and an established specialist-care culture. Suppliers benefit from demand for clinically credible platforms supported by technical service and evidence-oriented purchasing discussions.
UK
The UK market is projected to reach USD 6.1 million by 2035 and represented 18% of European revenue in 2025. Corporate consolidation and established referral networks support the use of standardized emergency-care equipment. The commercial opportunity favors suppliers that can serve multi-site accounts while maintaining responsive local service support.
France
France generated USD 3.3 million in 2025 and is projected to grow at a 5.2% CAGR (2026–2035). A broad base of general practices and referral facilities supports steady demand. Procurement is increasingly influenced by the development of emergency-medicine skills and by investment in better-equipped veterinary teaching and specialty settings.
Italy
Italy is projected to reach USD 6.8 million by 2035 and is expected to expand at a 4.9% CAGR (2026–2035). Demand is supported by private investment in advanced companion-animal care, particularly in urban and referral settings. Growth depends on the pace at which specialist facilities translate rising pet-owner expectations into capital-equipment upgrades.
Spain
Spain generated USD 3.1 million in 2025 and is projected to reach USD 5.1 million by 2035. The country's market is supported by companion-animal demand and ongoing investment in upgraded clinical infrastructure. Teaching hospitals and specialist practices provide important pathways for adoption of current-generation emergency equipment.
Netherlands
The Netherlands is projected to reach USD 3.6 million by 2035 and is forecast to advance at a 4.6% CAGR (2026–2035). The market is mature, with demand centered on technology refreshes and high clinical standards rather than extensive first-time adoption. Suppliers must demonstrate clear workflow or service advantages to displace installed equipment.
Asia Pacific Veterinary Defibrillators Market Analysis
The veterinary defibrillators market in Asia Pacific is projected to expand at a 7.6% CAGR (2026–2035) and account for 26% of global revenue in 2035. Asia Pacific combines expanding companion-animal ownership with ongoing development of urban veterinary infrastructure. The region's opportunity is more additive than replacement-led, but market access depends on appropriate pricing, local support, and the ability to navigate diverse regulatory and distribution conditions.
China
China generated USD 6.6 million in 2025 and is projected to reach USD 13.9 million by 2035. Urban pet ownership, expanding specialty-hospital networks, and domestic manufacturing capacity support China's role as a major regional demand center. Local suppliers and international participants alike must compete on functionality, price positioning, and service reach.
Japan
Japan is projected to generate USD 7.2 million by 2035 and account for 21% of Asia Pacific revenue in 2035. Japan's sophisticated small-animal care market supports demand for advanced, high-specification platforms. Purchasing decisions are shaped by clinical quality, reliability, and fit with established referral pathways rather than basic access to equipment.
India
India represented 15% of Asia Pacific revenue in 2025 and is projected to grow at an 8.2% CAGR (2026–2035). India's opportunity reflects the gradual formalization of specialty veterinary infrastructure in major urban markets. Market development will depend on affordable configurations, accessible training, and commercially viable service models for a diverse practice base.
Australia
Australia is projected to reach USD 3.1 million by 2035 and represented 10% of Asia Pacific revenue in 2025. The country's developed companion-animal healthcare system supports demand for dedicated emergency-care equipment. Corporate networks and established specialty practices create a relatively receptive market for premium, integrated platforms.
South Korea
South Korea generated USD 1.6 million in 2025 and is projected to expand at a 7.2% CAGR (2026–2035). Rising urban pet ownership and investment in specialty care are strengthening demand. The market offers attractive growth potential for suppliers that can align technology, price, and service delivery with the needs of rapidly developing clinic networks.
Latin America Veterinary Defibrillators Market Analysis
Latin America generated USD 3.7 million in 2025 and is projected to reach USD 6.6 million by 2035. The region's demand base is supported by urban companion-animal care and a gradual rise in specialist clinical capability. Import dependence, regulatory complexity, and capital-budget sensitivity remain meaningful constraints, elevating the importance of channel execution and cost-effective product offerings.
Brazil
Brazil generated USD 1.9 million in 2025 and represented 50% of Latin American revenue in 2025. Brazil is the region's principal demand center, with specialist hospitals in major cities driving adoption of advanced veterinary equipment. Its scale makes it a strategic market for suppliers establishing regional distribution and clinical-support operations.
Mexico
Mexico is projected to generate USD 2.0 million by 2035 and is expected to grow at a 6.2% CAGR (2026–2035). Investment in formal veterinary infrastructure is increasing in major metropolitan areas. Proximity to North American supply channels may support product availability, although price sensitivity and service coverage remain critical commercial considerations.
Argentina
Argentina represented 20% of Latin American revenue in 2025 and is forecast to expand at a 5.5% CAGR (2026–2035). Underlying demand is supported by a large companion-animal population and developing specialist care. Capital-equipment purchasing, however, remains sensitive to the operating conditions faced by clinics and distributors.
Middle East & Africa Veterinary Defibrillators Market Analysis
Middle East & Africa represented 3% of global revenue in 2025 and is projected to reach USD 3.9 million by 2035. The region combines premium companion-animal care development in selected Gulf markets with more gradual infrastructure expansion elsewhere. Procurement is concentrated in higher-specification facilities, making distributor capability, regulatory readiness, and clinical-service support important market-entry requirements.
Saudi Arabia
Saudi Arabia generated USD 0.8 million in 2025 and represented 36% of Middle East & Africa revenue in 2025. Investment in modern veterinary facilities and rising companion-animal ownership in urban centers support market development. Larger facilities and internationally connected operators are likely to remain the principal purchasers of advanced defibrillation platforms.
UAE
The UAE is projected to reach USD 1.1 million by 2035 and is expected to grow at a 6.2% CAGR (2026–2035). The UAE's premium clinic environment supports demand for current-generation equipment and internationally recognized clinical standards. Suppliers can differentiate through product quality, training, and rapid service responsiveness.
South Africa
South Africa represented 23% of Middle East & Africa revenue in 2025 and is projected to grow at a 6.1% CAGR (2026–2035). Demand is centered on established urban companion-animal care markets and specialist small-animal hospitals. The market offers a relatively developed entry point within sub-Saharan Africa for suppliers capable of supporting technical service and clinical education.
GMI Analyst View
We expect regional performance to diverge by the nature of investment rather than by clinical need alone. Mature markets will reward suppliers that win replacement and upgrade cycles, whereas Asia Pacific and selected emerging markets will favor companies that can make first-time adoption commercially practical through localized distribution, service, and price architecture.
Veterinary Defibrillators Market Share & Competitive Landscape
The veterinary defibrillators market share landscape is moderately fragmented, with the top five companies accounting for approximately 41% of global revenue in 2025. Competition centers on biphasic technology, integrated monitoring, veterinary-specific usability, regulatory readiness, channel coverage, and the ability to provide technical and clinical support after installation.
Mindray Medical International Limited held a 15% market share in 2025. Mindray's position is supported by its veterinary-focused product portfolio and broad medical-device distribution infrastructure. Its ability to offer integrated monitoring and defibrillation solutions creates an advantage with hospitals seeking to consolidate critical-care equipment purchases.
Shenzhen Comen Medical Instruments held an 8% market share in 2025. Comen competes through value-oriented defibrillator-monitor configurations and expansion through emerging-market distribution channels. The company's competitive relevance rests on balancing accessible pricing with the functionality expected by upgrading veterinary practices.
Digicare Biomedical held a 7% market share in 2025. Digicare's veterinary specialization and presence in emergency and specialty-care settings support a clinically focused market position. Training, product support, and monitoring-system familiarity can strengthen retention among demanding referral and critical-care customers.
Avante Animal Health held a 6% market share in 2025. Avante participates through new and certified-refurbished equipment supply, offering a cost-accessible route for practices evaluating alternatives to purpose-built premium systems. This positioning is especially relevant where capital constraints outweigh demand for the newest integrated functionality.
Meditech Equipment held a 5% market share in 2025. Meditech serves the market with manual defibrillator-monitor and AED configurations distributed across multiple geographies. Its ability to address different budget levels and channel requirements supports its role in a market where purchasing conditions differ sharply by practice type and region.
The remaining competitive field includes ARI Medical Technology, Chongqing Vision Star Optical, Hefei Eur Vet Technology, Infinium Medical, Kalstein, New Gen Medical Systems, Promed Technology, Shinova Medical, and Wuhan Union Medical Technology. These companies compete through regional distribution, OEM relationships, product breadth, pricing, and responsiveness to local service requirements. Qualification barriers remain meaningful, as veterinary purchasers assess not only device specifications but also training availability, maintenance support, and confidence in clinical performance.
Recent Industry Developments
IDEXX Laboratories announced the Catalyst proBNP Test, a dual-species in-clinic NT-proBNP test for cats and dogs, on August 12, 2026 [6]IDEXX Laboratories, Inc. “IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test.” ir.idexx.com. The development is relevant to the veterinary defibrillators market because broader point-of-care cardiac assessment may strengthen earlier identification and monitoring of companion-animal heart disease, reinforcing the clinical rationale for emergency preparedness in veterinary practice.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →